imciromab pentetate

fms related receptor tyrosine kinase 4 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28816016 The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer. 2018 Jan 1
2 23868727 Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma. 2015 Jan 1
3 24780592 Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction. 2014 Jun 10 1
4 19610651 Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo. 2009 Aug 13 1